Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Oriola Q4’24: Write-down weighed on reported earnings

By Rauli JuvaAnalyst
Oriola

Oriola's Q4 earnings were largely in line with expectations, but the reported earnings were weighed down by the previously announced write-down. The company guides for improved earnings this year. Oriola's CEO Katarina Gabrielson interviewed by analyst Rauli Juva.

Topics:
00:00 Intro
00:09 Operating model renewal and changes in the management team
02:19 MedInfo acquisition
03:58 Earnings on par with the comparison period excluding Swedish dose dispensing
04:35 Pharmacy joint venture's result was negative
05:07 Dividend policy
05:56 Change in guidance
06:53 Drivers for 2025
07:25 Reaching profitability levels comparable to Kronans Apotek's industry

Stay up to date
Company management interviews

Recent videos

Dustin Group, Audiocast, Q2'26
15.04.2026, 09.30 Dustin Group
HCA Morgenbørs 15/04 - Negative markeder og fokus på Tryg efter Q1
15.04.2026, 09.26 DFDS
HCA Morgenbørs 14/04 - Markedet forsøger at løfte sig
14.04.2026, 09.25 Demant
Carasent, Audiocast, Q1'26
14.04.2026, 08.00 Carasent
Revenio’s press conference on the Visionix acquisition
13.04.2026, 13.00 Revenio Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.